Anti-CD19-CAR-transduced-T-cells/blinatumomab/inotuzumab ozogamicin
- 22 February 2020
- journal article
- case report
- Published by Springer Science and Business Media LLC in Reactions Weekly
- Vol. 1792 (1), 23
- https://doi.org/10.1007/s40278-020-75131-5
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemiaCurrent Research in Translational Medicine, 2019